Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Howard Levy, MD, PhD, MMM
Catalyst Biosciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hematology Center After Prof. R. Yeolyan
Yerevan, Armenia
- Jsc "k.Eristavi National Center of Experimental and Clinical Surgery"
Tbilisi, Georgia
- Ltd M.Zodelava Hematology Centre
Tbilisi, Georgia
- Ltd Medinvest - Institute of Hematology and Transfusiology
Tbilisi, Georgia
- Gabinet Lekarski, Bartosz Korczowski
Rzeszów, Poland
- Regional Clinical Hospital
Kemerovo, Russia
- Fgu Kirov Scientific Research
Kirov, Russia
- Center for Hemophilia Treatment
Saint Petersburg, Russia
- Haemophilia Comprehensive Care Centre
Johannesburg, South Africa
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Dec 2017
- Primary completion
- 15 Mar 2019
- Completion
- 13 Apr 2019
- Last update posted
- 23 Sept 2021
- Registered enrollment
- 11
- Registry id
- NCT03407651
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.